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Background: The use of colonic stents has signiﬁcantly evolved over the last few years. Emergency
surgery for colonic obstructions is usually associated with signiﬁcant mortality, morbidity and often
stoma formation. Colonic stents provide an alternative way to relieve colonic obstruction, and hence
avoiding the risks associated with emergency surgery. This literature review aims to summarize the
important current evidence regarding colorectal stenting and show whether further evaluation of the
procedure is required.
Results: The available large number of non-randomized studies suggests that Self-Expandable-Metal-
Stents (SEMS) placement for acute colonic obstruction could be considered as safe and effective alter-
native to surgery in experienced hands either as a bridge to surgery or as a palliative measure. This
evidence has led to SEMS being widely adopted. However, randomized evidence has begun to show the
defects that are inherent in the low level evidence that has so far supported SEMS use and it may be that
reports of randomized controlled trials may clarify the patient population where SEMS placement is
appropriate.
Conclusion: While we are still waiting for the outcome of the multicentre randomized controlled trials in
the UK and Europe, clinicians must be aware of the current evidence limitations and apply SEMS use
pragmatically.
 2011 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Stenting of the colonic strictures was ﬁrst proposed in the early
nineties as a method of potentially converting emergency surgery
for obstructing colorectal cancers (CRC), with its associated
mortality and morbidity, to safer elective surgery.1 Reports rapidly
followed of colorectal stent placement to relieve malignant and
benign strictures both as a bridge to deﬁnitive surgery or as pallia-
tive treatment forobstructing cancer.2e4 Techniques haveevolved to
produce high clinical and technical success rates in a variety of
settings.5 This review aims to summarize the important current
evidence regarding colorectal stenting and show where further
evaluation of the technique is required.1.1. Search methods
Electronic search of databases (Pubmed/Medline, Ovid, Black-
well Synergy and Cochrane database) in addition to the search
engines Google/Google Scholar and Bing. The search was limited to: þ44 191 2932578.
maraee).
ciates Ltd. Published by Elsevier Ltarticles published mainly over the last ﬁve years in English
language. In addition, older publications were used to provide
a background for the subject. Searches were screened and those
studies thought to be relevant had full text versions retrieved. The
references of all retrieved texts were searched for further relevant
studies.
2. What is the role/evidence of colorectal stents in the
emergency setting?
Eight to twenty nine percent of CRC patients are initially pre-
sentedwith acute colonic obstruction. Seventy percent already have
an advanced cancer on presentation and only (50%) are candidates
for curative surgery.6,7 Emergency surgery for acute colonic
obstruction is associated with a mortality of (15e20%) and
amorbidity of (40e50%); both ofwhich are signiﬁcantly higher than
the elective colorectal surgery, where the mortality rate ranges
between (0.9e6%).8
The use of endoluminal colonic stents has signiﬁcantly evolved
over the last few years. They provide an alternative way to relieve
colonic obstruction to emergency surgery, which is usually asso-
ciated mortality, morbidity and often stoma formation. Successfuld. All rights reserved.
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prepare patients with resectable cancer for deﬁnitive elective
surgery. This time can be used for nutritional, organ and psycho-
logical support, tumor staging and neo-adjuvant therapy. It also
allows the involvement of specialist colorectal surgeons. Several
small retrospective series have examined the results of post-stent
deﬁnitive surgery with morbidity and mortality similar to
accepted elective surgical rates.9,10 Recent reports suggest that
laparoscopic surgery after colonic stenting appears to be successful
and safe.10e13
Despite encouraging results fromcase series and case-controlled
data, similar results have not been consistently replicated in the
randomized controlled trials comparing emergency surgery vs. Self
Expandable Metal Stent (SEMS) as a bridge to surgery. One multi-
centre trial was terminated early due to a high rate of technical
failure in the SEMS arm (54%) and a high perforation rate (7%) Using
an Intention to treat analysis, no difference was observed in the
stoma creation rate between the SEMS and emergency surgery
group. They suggested that the low rate of technical success may
reﬂect the inability to choose suitable cases for stenting in
a randomized trial setting.14 In April 2011, the collaborative Dutch
Stent-In study group has published a multi-centre randomized
controlled trial to compare [colonic stenting (n ¼ 47 patients) vs.
emergency surgery (n ¼ 51)]. This trial has shown that colonic
stenting has no decisive clinical advantages to emergency surgery.
The most common serious adverse events they have experienced
are abscess (three in the colonic stenting group vs. four in the
emergency surgery group), perforations (six vs. none), and anasto-
motic leakage (ﬁve vs. one), and the most common adverse events
were pneumonia (three vs. one) andwound infection (one vs. three).
The trial was stopped before reaching their calculated sample size of
(110) patients because of the substantial morbidity and some
mortality occurred in the colonic stenting after (30) days from the
stenting time. They advised that colonic stents could be used as an
alternative treatment in as yet undeﬁned subsets of patients.15
In contrast, Cheung et al. speciﬁcally set out to compare lapa-
roscopic surgery posts SEMS vs. Open emergency surgery. Their
trial was smaller (48 patients) and did not report an a priori power
calculation. Technical and clinical success was 83% after SEMS
insertion and no perforations were reported. Subsequent laparo-
scopic resection was successful in all cases.16 Two further trials are
anticipated in this area; the Colo Rectal Stenting Trial (CReST) and
the Enteral Stents for Colonic Obstruction (ESCO) trial. Both studies
are currently recruiting participants.17,18
3. What is the role/evidence of colorectal stents in the
palliative setting?
Colonic stents can also be used as a palliative measure for
patients with advanced non-resectable CRC or for those who are
considered to be medically unﬁt for surgery. They can alleviate
obstructive related symptoms and avoid stoma formation.19,20 As
with bridge-to-surgery much of the evidence is in the form of
retrospective case series which have been summarized in review
articles, Khot et al. presented pooled data of 336 palliative stents
reported in the literature and found the success rate was (90%) with
a re-obstruction rate of 10%.19 More recent pooled estimates, with
larger patient numbers, report similar data.8,20 Again the higher
level evidence would initially appear to conﬂict with results from
retrospective data. In 2006 the [Dutch In-stent 1 trial] closed after
recruiting only 21 patients due to a perforation in 4 of 11 patients in
the SEMS arm.21 In a subsequent report this increased to 6 perfo-
rations (greater than 50%).22 The perforations were not immediate
(earliest 12 days) and as such unlikely to be due to technical
problems with deployment. The authors suggested that they maybe related to the type of stent selected for all participants in the trial
or the combination of stenting and palliative chemotherapy
increasing risk of late perforation.22 The only other randomized
controlled trial (22 participants) in this setting compared stenting
with colostomy and reported equality in terms of morbidity and
mortality.23
4. When is a colonic stent contraindicated?
The absolute contraindication for colonic stenting is clinical or
radiological evidence of perforation, and low rectal tumors within
(5 cm) of the anal vergewhere stenting is liable to cause severe anal
pain, tenesmus or incontinence. Relative contraindications include
anatomical difﬁculties such as long stricture segment, or strictures
positioned in tortuous colonic segments and bowel ischemia.24e27
5. What is the role of stenting in the proximal colon?
In the early stages, the range at which a colonic stent could be
deployed was limited by the fact that there were no dedicated
colonic stents available. Oesophageal stents were adapted instead,
but there relatively short length made the proximal colon inac-
cessible. The ﬁrst case of proximal colonic stenting was reported in
Aberdeen in 1997 for an obstructing cancer in the proximal trans-
verse colon. At the time of developing the obstruction the patient
was being treated for bilateral ilio-femoral thrombosis and was
considered to be high risk for laparotomy. The stent remained in
situ for 10 weeks whilst the thrombus was treated and the patient
had an uneventful right hemicolectomy thereafter.28
Stenting in the proximal colon has not been as popular as surgery
has been the standard management for proximal obstructive
lesions. This is probably due to the fact that emergency right colonic
resections were widely considered safer with fewer complications
than emergency surgery for left colonic lesions. However data from
large series do not support this assumptionwith mortality and leak
rates equivalent to or increased after surgery for proximal compared
to distal obstruction,29,30 thus the beneﬁts of stenting as a bridge to
surgery may be similar to those seen for stenting in distal obstruc-
tion as discussed earlier. The evidence though is mainly limited to
small retrospective case series which compare proximal to distal
stenting but not surgery.
Elsberger et al. reported one of the ﬁrst series of proximal stents.
All but one were placed for palliation; four in the transverse colon
and three at the splenic ﬂexure. Technical and clinical success was
achieved in six patients using a combined colonoscopic and
radiological technique. However, all the lesions in this series were
incompletely obstructed (conﬁrmed by water soluble enema).31
Dronamraju et al. reported a series of 16 proximal stents; eight
lesions in the transverse colon and eight in the ascending colon.
Technical and clinical success remained high; 14/16 (87.5%) with
proximal lesions vs. 60/81 (78.9%) with distal lesions stented in the
same time. Complications were also equivalent in both groups (7.1%
vs. 8.6%).32
Repici et al. report a slightly larger series of 21 patients with
complete obstruction in eight and incomplete in 13. Technical
success was achieved in 20 patients (95%) and clinical success in 17
(85%). There were no immediate complications and all eight
patients who subsequently underwent resection had uneventful
postoperative courses.33
Kim et al. examined the effects of stenting on later post resection
outcomes depending on the location of the stent. Their deﬁnition of
a proximal lesion was one proximal to the sigmoid colon. Their
series was relatively large (57 patients) but evenwith the relatively
‘distal’ deﬁnition of proximal they only had 13 patients in this
group. However there were no difference detected between the
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complications, intensive care unit (ICU) stay, hospital stay and
mortality.34
Although these series are individually small and hence repre-
sent low level evidence the heterogeneity of the results is reas-
suring. Technical and clinical success rates reported are similar to
the pooled results reported in a 2002 meta-analysis of all stent
results published of 92% and 88% respectively.19 However there
may be an element of reporting bias in the literature on proximal
stents. Although several of the studies mention that proximal stent
placement is no more difﬁcult than distal placement, it is also likely
that endoscopists or radiologists who attempt to stent proximal
lesions already have signiﬁcant expertise in stenting distal lesions.
It is therefore likely that proximal stents are as successful and safe
as distal stents in appropriately experienced hands.
6. What is the role of colorectal stents in extrinsic
obstruction?
Whilst many case series include small numbers of SEMS place
for extrinsic disease the only series to examine this speciﬁcally has
been reported by Shin in et al.35 They initially hypothesized that
stent placement in this setting may be more difﬁcult, as the colon is
often immobilized due to extrinsic invasion, and unlike CRC, the
interior of the colonic wall remains smooth making stent bedding-
in more difﬁcult and promote stent migration. In a multivariate
analysis, underlying extracolonic malignancy was the predictor of
failure for colonic stent placement whereas a history of radiation
therapy was the sole predictor of complications.36
7. What are the different stent types of colorectal stents?
what are their drawbacks and advantages?
Various types of self-expanding metal stent (SEMS) are avail-
able. Once deployed, SEMS expand over 24e72 h to become
incorporated into both the tumor and surrounding tissue by pres-
sure necrosis, anchoring the stent. SEMS can be covered or
uncovered; both have similar technical and clinical success.26,37
There has been suggestion that covered stents have higher rates
of migration whilst they may resist tumor in-growth.38 Covered
stents can be used to close ﬁstulae with generally good results
reported.39e41 Pragmatically the choice of stent will bemade on the
basis of the stent indication, anticipated time of placement as well
as operator and institutional factors such as previous experience,
facilities and cost.
8. How does colorectal stents insertion affect colonic
imaging?
Computed Tomography (CT) colonography is a reasonably
sensitive and speciﬁc pre-operative evaluation tool to rule out
synchronous lesions in the proximal colon.42 Sensitivity and spec-
iﬁcity of CT colonography for synchronous lesions do not appear to
be negatively affected by the placement of SEMS. Bowel prepara-
tion and colonic insufﬂation do not appear to cause migration of
stents or other complications.43
Most SEMS materials appear safe for Magnetic Resonance
Imaging (MRI); which is important for future rectal tumors staging,
but factors such as stent shape, orientation to the magnetic ﬁeld,
and type of alloy composition inﬂuence signal intensity in vitro.26
Despite the lack of speciﬁc colorectal stents MRI scan safety
studies, extensive studies were carried out about their biliary,
vascular and oesophageal relatives.44,45 MRI has minimal degrada-
tion effects and neglected migration chances especially in the non-
stainless steel stents.9. What is post procedure care?
Post-procedural care is largely not evidence based. After
successful stent insertion, patients are observed for at least 24 h.
Plain abdominal X-ray is usually done to assess the position and
expansion of the stent at 24 h. Any clinical suspicion of perforation
mandates immediate imaging and surgery if conﬁrmed. In clinically
successful cases patients can resume oral intake immediately.26
Although not evidence based it seems logical that where the indi-
cation is palliative patients should receive advice regarding low-
residue diet and commence regular stool softeners to prevent
stent occlusion.25,26 Patients should be educated about the symp-
toms of re-obstruction and action to be taken if this occurs. Re-
obstruction due to tumor invasion or overgrowth can be managed
by laser re-canalization or re-stenting with or within the old stent.
Currently, it seems that there is no strong evidence available that
looked into timing of performing surgery after colonic stenting.
10. Overall what are the complications of colorectal stents
deployment?
The occurrence of perforation varies greatly across the literature
and can occur as an immediate or delayed complication. The usual
risk is quoted is less than 4%19; however, recent randomized
evidence has thrown this ﬁgure into doubt for unselected pop-
ulations.22,14 Perforations could immediate or delayed. The reason
behind the perforation’smechanism is not very clear, and perhaps it
ismultifactorial like guidewire deployment, stricture dilatation, site
and length of the obstructive lesion, chemotherapy and type of the
stent. More studies are needed to look speciﬁcally into this matter.
Technical or clinical failure have both been low in most reported
series19; however, randomized evidence is now being reported
with much higher failure rates.22,14
Stent occlusion due to faecal impaction or tumor overgrowth is
a particular problem in palliative patients where stents remain in
situ for longer periods of time. Re-obstruction has been reported in
60% of cases at 300 days.46 Song et al assessed the use of a dual-
design stent, consisting of an outer stent and inner bare nitinol
stent intended to reduce the delayed complications of in-growth
obstruction and migration. One hundred and ﬁfty one patients
were included in the trial; initial technical success was over 90%,
but the perforation rate was high (16/151-11%), this being more
common in patients with complete obstruction. Tumor overgrowth
occurred in 5 of the 95 patients treated with palliative intent
(5.2%).24
Stent migration could happen in the early phase usually
following pre-placement laser canalization, chemotherapy or in
stented benign stricture lesions.19 Migrated stents usually removed
endoscopically with no further intervention as it indicates resolu-
tion of luminal stricture.19
11. Are stents economically viable?
Data using American insurance claim data suggest that SEMS
placement economically viable compared with surgical creation of
the colostomy with a shorter mean hospital stay (8 vs. 12 days) and
reduced cost ($15.071 vs. $24.695).47 These include all U.S. Medi-
care claims for either colonic stent placement or colostomy but
importantly, claims for both procedures i.e. those likely to relate to
failed stents were excluded.
12. Conclusion
The available large number of non-randomized studies suggests
that SEMS placement for acute colonic obstruction due to cancer
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experienced hands either as a bridge to surgery or as a palliative
measure. This evidence has led to SEMS being widely adopted in
many centers. However randomized evidence has begun to show
the defects that are inherent in the low level evidence that has so
far supported SEMS use and it may be that reports of randomized
controlled trials may clarify the patient population where SEMS
placement is appropriate. Meanwhile, the implementation of stents
to relieve colonic obstruction in practice should only be done in
centers where expertise is available. Cliniciansmust be aware of the
current evidence limitations and apply SEMS use pragmatically.
The patients should be selected carefully before the procedure. The
procedure should be explained clearly to the patients; including the
risks and beneﬁts. Long term follow up plans should be imple-
mented to assess the long term complications of the stents.
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